| CAGR | +22.6% | +9.2% | +16.7% | +17.5% |
| Sharpe | 0.24 | 0.14 | 0.63 | 0.65 |
| Sortino | 0.40 | 0.24 | 1.24 | 1.26 |
| Corr to S&P500 | 0.80 | 0.90 | 0.91 | 0.93 |
| Capture+ | +0.72 | +0.74 | +0.88 | +0.93 |
| Capture- | +0.79 | +0.83 | +0.72 | +0.78 |
| Capture ratio | 0.91 | 0.89 | 1.21 | 1.19 |
| Beta | 0.34 | 0.58 | 0.67 | 0.72 |
| MDD | -25% | -26% | -28% | -28% |
The fund invests at least 80% of assets in securities of companies principally engaged in the design, manufacture, or sale of products or services used for or in connection with health care or medicine. It invests primarily in common stocks. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.